期刊文献+

添加马来酸桂哌齐特治疗急性脑梗死的疗效观察 被引量:3

Clinical Study of Addition Cinepazide Maleate in the Treatment of Acute Cerebral Infarction
原文传递
导出
摘要 目的研究添加马来酸桂哌齐特治疗急性脑梗死的临床疗效。方法将90例急性脑梗死患者随机分成对照组和治疗组,每组45例,对照组采用急性脑梗死的常规药物治疗,治疗组在对照组常规治疗的基础上给予马来酸桂哌齐特静脉滴注,14 d后观察其疗效。结果经14 d的治疗后治疗组与对照组的神经功能缺损评分、日常生活能力评分及临床疗效比较差异有统计学意义(P<0.05)。结论在常规药物治疗基础上加用马来酸桂哌齐特可有效改善急性脑梗死患者的神经功能缺损情况,提高日常生活能力,疗效确切。 OBJECTIVE To evaluate the effect of addition cinepazide maleate treating on acute cerebral infarction. METHODS All of 90 patients with acute cerebral infarction were randomly divided into 2 groups with 45 patients in each group: The patients in the control group were received conventional drug treatment, while the patients in the treatment group were treated with conventional drug treatment with the addition of cinepazide maleate to observe the effects. RESULTS After 14 days, compared with control group, nerve function defect score, daily life ability score and the clinical curative effect in the patients of treatment group had significant statistical difference(P〈0.05). CONCLUSION With the routine treatment, adding cinepazide maleate can improve the patients with acute cerebral infarction of nervous function loss situation, and improve the ability of daily life, and has a good curative effect.
作者 卢爱军
出处 《中国现代应用药学》 CAS CSCD 2013年第6期679-682,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 马来酸桂哌齐特 急性脑梗死 cinepazide maleate acute cerebral infarction
  • 相关文献

参考文献1

二级参考文献26

  • 1李小松,朱伟伟,邱晓虹,张金哲.序贯疗法改善大鼠小肠移植慢性排斥反应的实验研究[J].首都医科大学学报,2010,31(2):201-205. 被引量:2
  • 2Fleming S D,Tsokos G C.Complement,natural antibodies,autoantibodies and tissue injury[J].Autoimmune Rev,2006,5:89-92.
  • 3Huang Y,Rabb H,Womer K L,et al.Ischemia-reperfusion and immediate T cell responses[J].Cell Immunol,2007,248:4-11.
  • 4Burne M J,Daniels F,Ghandour A E,et al.Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure[J].J Clin Invest,2001,108:283-1290.
  • 5Mosmann T R,Cherwinski H,Bond M W,et al.Two types of murine helper T cell clone.I.Definition according to profiles of lymphokine activities and secreted proteins[J].J Immunol,1986,136:348-2357.
  • 6Steinman L.A brief history of TH17,the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage[J].Nat Med,2007,13:39-147.
  • 7Moseley T A,Haudenschild D R,Rose L,et al.Interleukin-17 family and IL-17 receptors[J].Cytokine Growth Factor Rev,2003,14:55-174.
  • 8Shigematsu T,Wolf R E,Granger D N.T-lymphocytes modulate the microvascular and inflammatory responses to intestinal ischemia-reperfusion[J].Microcirculation,2002,9:99-109.
  • 9Lu L,Li G,RAO J,et al.In vitro induced CD4(+)CD25(+)Foxp3(+)Tregs attenuate hepatic ischemia-reperfusion injury[J].Int Immunopharmacol,2009,9:549-552.
  • 10Shichita T,Sugiyama Y,Ooboshi H,et al.Pivotal role of cerebral interleukin-17 producing gama delta T cells in the delayed phase of ischemic brain injury[J].Nat Med,2009,15:946-950.

共引文献11

同被引文献42

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部